Anti-Breast Cancer Effect of 2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione in vivo and in vitro Through MAPK Signaling Pathway [Corrigendum]

• Main Authors: Zhou X, Wu X, Qin L, Lu S, Zhang H, Wei J, Chen L, Jiang L, Wu Y, Chen C, Huang R
• Format: Article
• Language: English
• Published: Dove Medical Press 2020-10-01
• Series: Drug Design, Development and Therapy
• Subjects: dmdd; breast cancer; mapk signaling pathway; bcl-2 family.
• Online Access: https://www.dovepress.com/corrigendum-anti-breast-cancer-effect-of-2-dodecyl-6-methoxycyclohexa--peer-reviewed-article-DDDT
• ISSN: 1177-8881

Zhou X, Wu X, Qin L, et al. Drug Des Devel Ther. 2020;14:2667–2684. The authors have advised when preparing the images for Figure 5A on page 2675, the incorrect image was used for the 0 h DMDD H group. This inadvertently led to the duplication of images for the DMDD M group and DMDD H group. The correct Figure 5 is shown below.    The authors have also advised the incorrect image was used for Figure 14C on page 2682 which inadvertently led to the duplication of images for RAF1 in Figure 14A and GAPDH in Figure 14C. The correct Figure 14 is shown below. The authors apologize for these errors and advise they do not affect the results of the paper.   Read the original article